TriSalus Life Sciences, Inc. SEC filings TLSI

TriSalus Life Sciences, Inc. has 493 filings in SEC EDGAR's recent list, going back to Oct 29, 2020. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 22, 2026 (other events). The company's fiscal year ends on December 31.

TriSalus Life Sciences, Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Sep 22, 2026 Sep 22, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Shareholder vote results
May 14, 2026 May 14, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
8-K Current report
Officer or director change
Apr 29, 2026 Apr 24, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 7, 2026 Apr 1, 2026
ARS Annual report to shareholders Mar 31, 2026 Dec 31, 2025
DEFA14A Additional proxy material Mar 31, 2026 —
DEF 14A Proxy statement Mar 31, 2026 Dec 31, 2025
S-8 Employee stock plan registration Mar 10, 2026 —
10-K Annual report Mar 5, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 5, 2026 Mar 5, 2026
424B5 Prospectus supplement Feb 26, 2026 —
424B5 Prospectus supplement Feb 20, 2026 —
8-K Current report
Material agreement, Other events
Feb 20, 2026 Feb 19, 2026
424B5 Prospectus supplement Feb 19, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 9, 2026 Feb 3, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
EFFECT Filing Dec 4, 2025 —
CORRESP Letter to the SEC Dec 2, 2025 —
S-3 Shelf registration Nov 13, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
8-K Current report
Officer or director change
Oct 1, 2025 Sep 30, 2025
8-K Current report
Officer or director change
Aug 29, 2025 Aug 25, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
SC TO-I/A Filing Jul 25, 2025 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
Jul 24, 2025 Jul 24, 2025
EFFECT Filing Jul 22, 2025 —
SC TO-I/A Filing Jul 15, 2025 —
S-4/A Filing Jul 11, 2025 —
8-K Current report
Other events
Jun 23, 2025 Jun 23, 2025
S-4 Registration for a merger or exchange Jun 23, 2025 —
SC TO-I Filing Jun 23, 2025 —
8-K Current report
Shareholder vote results
Jun 16, 2025 Jun 12, 2025
EFFECT Filing Jun 11, 2025 —
CORRESP Letter to the SEC Jun 6, 2025 —
UPLOAD Letter from the SEC Jun 6, 2025 —
EFFECT Filing May 30, 2025 —
S-3 Shelf registration May 30, 2025 —
8-K Current report
Officer or director change, Other events
May 30, 2025 May 23, 2025
10-K/A Amended annual report May 30, 2025 Dec 31, 2024
CORRESP Letter to the SEC May 28, 2025 —
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
D Filing May 8, 2025 —
UPLOAD Letter from the SEC May 5, 2025 —
EFFECT Filing May 2, 2025 —
CORRESP Letter to the SEC Apr 30, 2025 —
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 30, 2025 Jun 12, 2025
UPLOAD Letter from the SEC Apr 30, 2025 —
425 Filing Apr 30, 2025 —
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
Apr 30, 2025 Apr 30, 2025
S-3 Shelf registration Apr 28, 2025 —
S-8 Employee stock plan registration Apr 25, 2025 —
S-3 Shelf registration Apr 25, 2025 —
8-K Current report
Officer or director change
Apr 23, 2025 Apr 20, 2025
8-K Current report
Officer or director change
Apr 17, 2025 Apr 16, 2025
10-K Annual report Apr 15, 2025 Dec 31, 2024
NT 10-K Filing Mar 28, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 27, 2025 Mar 27, 2025
8-K Current report
Officer or director change
Feb 25, 2025 Feb 19, 2025
8-K Current report
New debt, Unregistered share sale
Feb 19, 2025 Feb 18, 2025
8-K Current report
Results of operations
Feb 3, 2025 Jan 31, 2025
8-K Current report
Officer or director change
Jan 31, 2025 Jan 29, 2025
8-K Current report
Results of operations
Jan 23, 2025 Jan 23, 2025
8-K Current report
Officer or director change
Jan 8, 2025 Jan 4, 2025
D Filing Dec 30, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
EFFECT Filing Nov 8, 2024 —
EFFECT Filing Nov 8, 2024 —
EFFECT Filing Nov 8, 2024 —
EFFECT Filing Nov 8, 2024 —
CORRESP Letter to the SEC Nov 6, 2024 —
POS AM Filing Nov 6, 2024 —
UPLOAD Letter from the SEC Nov 4, 2024 —
8-K Current report
Officer or director change
Nov 1, 2024 Oct 28, 2024
S-3 Shelf registration Oct 29, 2024 —
POS AM Filing Oct 29, 2024 —
POS AM Filing Oct 29, 2024 —
POS AM Filing Oct 29, 2024 —
424B3 Prospectus Aug 15, 2024 —
424B3 Prospectus Aug 15, 2024 —
424B3 Prospectus Aug 15, 2024 —
8-K Current report
Results of operations, Shareholder vote results
Aug 15, 2024 Aug 13, 2024
424B3 Prospectus Aug 14, 2024 —
424B3 Prospectus Aug 14, 2024 —
424B3 Prospectus Aug 14, 2024 —
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
DEF 14A Proxy statement Jul 19, 2024 Jul 10, 2024
ARS Annual report to shareholders Jul 19, 2024 Jun 18, 2024
424B3 Prospectus Jul 1, 2024 —
424B3 Prospectus Jul 1, 2024 —
424B3 Prospectus Jul 1, 2024 —
425 Filing Jul 1, 2024 —
8-K Current report
Other events
Jul 1, 2024 Jul 1, 2024
SC TO-I/A Filing Jun 27, 2024 —
425 Filing Jun 27, 2024 —
8-K Current report
Material agreement, Change to shareholder rights, Shareholder vote results, Other events
Jun 27, 2024 Jun 26, 2024
424B3 Prospectus Jun 26, 2024 —
EFFECT Filing Jun 25, 2024 —
EFFECT Filing Jun 21, 2024 —
CORRESP Letter to the SEC Jun 20, 2024 —
UPLOAD Letter from the SEC Jun 18, 2024 —
S-1 Registration statement Jun 14, 2024 —
424B3 Prospectus May 24, 2024 —
424B3 Prospectus May 24, 2024 —
SC TO-I Filing May 24, 2024 —
425 Filing May 24, 2024 —
8-K Current report
Other events
May 24, 2024 May 24, 2024
S-4 Registration for a merger or exchange May 24, 2024 —
424B3 Prospectus May 15, 2024 —
424B3 Prospectus May 15, 2024 —
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
424B3 Prospectus May 7, 2024 —
424B3 Prospectus May 7, 2024 —
8-K Current report
Officer or director change
May 7, 2024 May 7, 2024
424B3 Prospectus Apr 30, 2024 —
424B3 Prospectus Apr 30, 2024 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Apr 30, 2024 Apr 30, 2024
EFFECT Filing Apr 24, 2024 —
EFFECT Filing Apr 24, 2024 —
POS AM Filing Apr 17, 2024 —
POS AM Filing Apr 17, 2024 —
8-K Current report
Auditor change
Apr 16, 2024 Apr 12, 2024
S-8 Employee stock plan registration Apr 11, 2024 —
10-K Annual report Apr 11, 2024 Dec 31, 2023
NT 10-K Filing Apr 2, 2024 Dec 31, 2023
8-K Current report
Results of operations
Apr 1, 2024 Apr 1, 2024
8-K Current report
Results of operations, Other events
Mar 12, 2024 Mar 11, 2024
424B3 Prospectus Jan 25, 2024 —
424B3 Prospectus Jan 25, 2024 —
8-K Current report
Officer or director change
Jan 25, 2024 Jan 24, 2024
8-K Current report
Results of operations
Jan 5, 2024 Jan 5, 2024
EFFECT Filing Dec 26, 2023 —
EFFECT Filing Dec 26, 2023 —
424B3 Prospectus Dec 26, 2023 —
424B3 Prospectus Dec 26, 2023 —
CORRESP Letter to the SEC Dec 21, 2023 —
CORRESP Letter to the SEC Dec 21, 2023 —
UPLOAD Letter from the SEC Dec 21, 2023 —
S-1 Registration statement Dec 15, 2023 —
S-1/A Amended registration statement Dec 15, 2023 —
CORRESP Letter to the SEC Dec 14, 2023 —
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
UPLOAD Letter from the SEC Nov 6, 2023 —
S-1/A Amended registration statement Oct 19, 2023 —
CORRESP Letter to the SEC Oct 18, 2023 —
S-8 Employee stock plan registration Oct 16, 2023 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 3, 2023 Oct 2, 2023
UPLOAD Letter from the SEC Sep 28, 2023 —
S-1/A Amended registration statement Sep 1, 2023 —
8-K Current report
Regulation FD disclosure
Sep 1, 2023 Sep 1, 2023
S-1 Registration statement Aug 31, 2023 —
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Aug 16, 2023 Aug 10, 2023
25-NSE Delisting notice Aug 10, 2023 —
425 Filing Aug 9, 2023 —
8-K Current report
Shareholder vote results, Other events
Aug 9, 2023 Aug 8, 2023
DEFA14A Additional proxy material Aug 2, 2023 —
425 Filing Aug 2, 2023 —
8-K Current report
Shareholder vote results, Other events
Aug 2, 2023 Aug 2, 2023
425 Filing Aug 2, 2023 —
8-K Current report
Other events
Aug 2, 2023 Aug 2, 2023
10-Q Quarterly report Aug 2, 2023 Jun 30, 2023
8-K Current report
Other events
Jul 21, 2023 Jul 17, 2023
SEC STAFF LETTER Filing Jul 18, 2023 —
EFFECT Filing Jul 18, 2023 —
424B3 Prospectus Jul 18, 2023 —
CORRESP Letter to the SEC Jul 14, 2023 —
S-4/A Filing Jul 14, 2023 —
S-4/A Filing Jul 11, 2023 —
CORRESP Letter to the SEC Jul 6, 2023 —
S-4/A Filing Jul 6, 2023 —
425 Filing Jul 6, 2023 —
8-K Current report
Material agreement, Agreement ended, Unregistered share sale
Jul 6, 2023 Jul 4, 2023
8-K Current report
Unregistered share sale
Jun 30, 2023 Jun 26, 2023
D Filing Jun 22, 2023 —
8-K Current report
Listing notice
Jun 21, 2023 Jun 14, 2023
UPLOAD Letter from the SEC Jun 20, 2023 —
8-K Current report
Material agreement, New debt, Bylaw or fiscal year change, Shareholder vote results
Jun 15, 2023 Jun 12, 2023
425 Filing Jun 12, 2023 —
8-K Current report
Regulation FD disclosure
Jun 12, 2023 Jun 12, 2023
CORRESP Letter to the SEC Jun 8, 2023 —
S-4/A Filing Jun 8, 2023 —
425 Filing Jun 8, 2023 —
8-K Current report
Material agreement, Unregistered share sale
Jun 8, 2023 Jun 7, 2023
UPLOAD Letter from the SEC May 31, 2023 —
SEC STAFF LETTER Filing May 25, 2023 —
DEF 14A Proxy statement May 24, 2023 Jun 12, 2023
CORRESP Letter to the SEC May 23, 2023 —
S-4/A Form s-4/a May 23, 2023 —
425 Filing May 15, 2023 —
8-K Current report
Material agreement
May 15, 2023 May 13, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
TLSI (Nasdaq), TLSIW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Westminster, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1826667
Former names
MedTech Acquisition Corp (until Aug 10, 2023); MedTech Acquisition Corporation (until Oct 29, 2020)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.